We evaluated the change in transcutaneous oxygen (tcPO2) and carbon dioxide (tcPCO2) tension in response to 60 minutes' infusion of Intralipid (Kabi Vitrum (Saphar)) (mean dose 0,16 ± 0,07 g/kg/h) in neonates with lung disease (hyaline membrane disease or bronchopulmonary dysplasia). The tcPO2 was 10% lower following Intralipid infusion (P < 0,05), whereas no significant change occurred in tcPO2 measurements. The data confirm the need for limited use of Intralipid in this category of patients.
|Number of pages||3|
|Journal||South African Medical Journal|
|Publication status||Published - 1987|